{"id":"NCT01811732","sponsor":"Melinta Therapeutics, Inc.","briefTitle":"Delafloxacin Versus Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections","officialTitle":"A Phase 3, Multicenter, Randomized, Double-blind, Active-controlled Study to Evaluate the Efficacy and Safety of Delafloxacin Compared With Vancomycin + Aztreonam in Patients With Acute Bacterial Skin and Skin Structure Infections","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-04","primaryCompletion":"2014-07","completion":"2014-07","firstPosted":"2013-03-15","resultsPosted":"2017-08-24","lastUpdate":"2017-09-27"},"enrollment":660,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Skin and Subcutaneous Tissue Bacterial Infections"],"interventions":[{"type":"DRUG","name":"Delafloxacin","otherNames":["RX-3341"]},{"type":"DRUG","name":"Vancomycin","otherNames":[]},{"type":"DRUG","name":"Aztreonam","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":["5% Dextrose","D5W"]}],"arms":[{"label":"Delafloxacin plus placebo","type":"EXPERIMENTAL"},{"label":"Vancomycin plus Aztreonam + placebo","type":"ACTIVE_COMPARATOR"}],"summary":"This study was designed to evaluate the efficacy of delafloxacin patients with acute bacterial skin and soft tissue infections (ABSSSI).","primaryOutcome":{"measure":"Objective Response at 48 to 72 Hours (FDA Primary Endpoint)","timeFrame":"48 to 72 hours after starting treatment","effectByArm":[{"arm":"Delafloxacin Plus Placebo","deltaMin":259,"sd":null},{"arm":"Vancomycin Plus Aztreonam + Placebo","deltaMin":266,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":5},"locations":{"siteCount":50,"countries":["United States","Croatia","Israel","Latvia","Russia","Spain","Ukraine"]},"refs":{"pmids":["30349845","29029278","28630189"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":12,"n":324},"commonTop":["Infusion site extravasation","Infection","Nausea","Diarrhea","Headache"]}}